TY  - CHAP
M1  - Book, Section
TI  - Upper Respiratory Tract Infections
A1  - Frei, Christopher
A1  - Frei, Bradi
A2  - DiPiro, Joseph T.
A2  - Talbert, Robert L.
A2  - Yee, Gary C.
A2  - Matzke, Gary R.
A2  - Wells, Barbara G.
A2  - Posey, L. Michael
Y1  - 2017
N1  - 
T2  - Pharmacotherapy: A Pathophysiologic Approach, 10e
AB  - Patient  Care  Process  for  Acute  Bacterial  RhinosinusitisCollectPatient  characteristics  (e.g.,  age,  weight)Patient  history  (e.g.,  past  infections,  current  and  past  antibiotic/antiviral  use  noting  previous  failures,  medication  allergies,  history  of  allergic  rhinitis)Determine  whether  patient  is  in  daycare,  is  a  daycare  worker,  or  has  a  child  in  daycareObjective  data:TemperatureSigns  and  symptoms  (see  Clinical  Presentation)Presence  of  congestion,  fullness,  or  pain  in  the  nose,  face,  or  earPresence  of  purulent  or  discolored  nasal  dischargeOther  diagnostic  tests,  when  indicated  (e.g.,  CT,  sinus  puncture)AssessInfection  status,  including  presence  of  signs  and  symptomsDetermine  which  symptoms  may  need  additional  therapy  (e.g.,  ongoing  nose  pain)Decide  if  referral  is  needed  (e.g.,  mental  status  changes,  visual  disturbances,  immunosuppressive  illness,  nosocomial  infections,  anatomic  defects,  unilateral  findings)Use  information  collected,  patient  factors  (e.g.,  patient  age,  symptom  severity),  and  joint  decision-making  with  parents/caregivers  to  determine  whether  antibiotics  are  neededIf  antibiotics  are  appropriate,  determine  proper  choice  of  antibiotic,  dose,  duration,  and  dosage  formDetermine  if  the  patient  meets  criteria  for  high-dose  amoxicillin-clavulanatePlanSelect  drug  therapy  regimen  including  specific  antibiotic,  dose,  route,  frequency,  and  duration;  specify  the  continuation  and  discontinuation  of  existing  therapies  (see  Tables  108-2  and  108-3)Monitor  efficacy  (e.g.,  temperature,  pain),  safety  (e.g.,  medication-specific  adverse  effects),  and  timeframeEducate  patient  and/or  caregiver  (e.g.,  purpose  of  treatment,  drug  therapy)  emphasizing  adherence  to  treatment  regimenRecommend  self-monitoring  of  body  temperatureImplementProvide  patient  education  regarding  the  infection  and  all  elements  of  treatment  planUse  motivational  interviewing  and  coaching  strategies  to  maximize  adherenceSchedule  follow-up,  when  indicatedRecommend  measures  to  reduce  nose  pain  and  inflammation,  if  presentFollow-up:  Monitor  and  EvaluateImprovement/resolution  of  signs  and  symptoms;  reassess  the  plan  if  the  patient’s  symptoms  worsen  or  decline  within  48  to  72  hours  of  symptom  onsetUse  of  nasal  decongestant  sprays  and  antihistamines;  these  are  not  recommended  for  treatmentPresence  of  adverse  effects,  particularly  allergic  reactions  and  diarrheaPatient  adherence  to  treatment  plan  using  multiple  sources  of  information  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/20
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1154961779
ER  -